Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils

Biochemical Pharmacology

Volumn 56, Issue 11, 1998, Pages 1505-1514

  Wang, Jih Pyang ^a,b   Raung, Shue Ling ^a   Huang, Li Jiau ^b   Kuo, Sheng Chu ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adenylate cyclase; Cyclic AMP; Neutrophil; Phosphodiesterase; Respiratory burst; YT 1

Indexed keywords

2 PHENYL 4 QUINOLONE; BUCLADESINE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; KT 5720; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE; PROSTAGLANDIN E1; QUINOLONE DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATORY BURST;

ADENYLATE CYCLASE; ALPROSTADIL; ANIMALS; BUCLADESINE; CALCIUM; CARBAZOLES; CARDIOTONIC AGENTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYTOSOL; INDOLES; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL PHOSPHATES; KINETICS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OXYGEN CONSUMPTION; PROTEIN KINASE C; PYRROLES; QUINOLONES; RATS; RESPIRATORY BURST; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0031769885     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00265-2     Document Type: Article

References (52)

1. Badwey J.A., Karnovsky M.L. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem. 49:1980;695-726.
2. Segal A.W., Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci. 18:1993;43-47.
3. phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem. 270:1995;6543-6548.
4. Smith R.M., Curnutte J.T. Molecular basis of chronic granulomatous disease. Blood. 77:1991;673-686.
5. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease An overview . Methods Enzymol. 186:1990;1-85.
6. Berridge M.J. Inositol trisphosphate and diacylglycerol Two interacting second messengers . Annu Rev Biochem. 56:1987;159-193.
7. Yasui K., Yamazaki M., Miyabayashi M., Tsuno T., Komiyama A. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor Distinct from the pathway for superoxide anion production . J Immunol. 152:1994;5922-5929.
8. Arcaro A., Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses . Biochem J. 296:1993;297-301.
9. 2 in the activation of the NADPH oxidase . Biochem J. 264:1989;249-255.
10. Nick J.A., Avdi N.J., Young S.K., Knall C., Gerwins P., Johnson G.L., Worthen G.S. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest. 99:1997;975-986.
11. Kuo S.C., Lee H.Z., Juang J.P., Lin Y.T., Wu T.S., Chang J.J., Lednicer D., Paull K.D., Lin C.M., Hamel E., Lee K.H. Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4′-substituted phenyl)-4-quinolones and related compounds Identification as antimitotic agents interacting with tubulin . J Med Chem. 36:1993;1146-1156.
12. Su M.J., Chang G.J., Kuo S.C. Mechanical and electrophysiological studies on the positive inotropic effect of 2-phenyl-4-oxo-hydroquinolone in rat cardiac tissues. Br J Pharmacol. 110:1993;310-316.
13. Wang J.P., Hsu M.F., Raung S.L., Kuo S.C. Suppressive effect of 2-phenyl-4-quinolone (YT-1) on hind-paw edema and cutaneous vascular plasma extravasation in mice. Naunyn Schmiedebergs Arch Pharmacol. 349:1994;324-330.
14. Wang J.P., Raung S.L., Kuo Y.H., Teng C.M. Daphnoretin-induced respiratory burst in rat neutrophils is, probably, mainly through protein kinase C activation. Eur J Pharmacol. 288:1995;341-348.
15. Goldberg B., Stern A. The role of the superoxide anion as a toxic species in the erythrocyte. Arch Biochem Biophys. 178:1977;218-225.
16. Ingraham L.M., Coates T.D., Allen J.M., Higgins C.P., Baehner R.L., Boxer L.A. Metabolic, membrane, and functional response of human polymorphonuclear leukocytes to platelet-activating factor. Blood. 59:1982;1259-1266.
17. Wang J.P., Raung S.L., Hsu M.F., Chen C.C. Inhibition by gomisin C (a lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils. Br J Pharmacol. 113:1994;945-953.
18. 2+. Biochem J. 269:1990;513-519.
19. Kao J.P., Harootunian A.T., Tsien R.Y. Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem. 264:1989;8179-8184.
20. Hannun Y.A., Loomis C.R., Merrill A.H. Jr, Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem. 261:1986;12604-12609.
21. Simchowitz L., Spilberg I., Atkinson J.P. Superoxide generation and granule enzyme release induced by ionophore A23187. Studies on the early events of neutrophil activation. J Lab Clin Med. 96:1980;408-424.
22. Roskoski R. Jr. Assays of protein kinase. Methods Enzymol. 99:1983;3-6.
23. Saad M., Strnad C.F., Wong K. Dual regulation of neutrophil adenylate cyclase by fluoride and its relationship to cellular activation. Br J Pharmacol. 91:1987;715-719.
24. Mittal C.K. Determination of adenylate cyclase and guanylate cyclase activities in cells of the immune system. Methods Enzymol. 132:1986;422-428.
25. Wright C.D., Kuipers P.J., Kobylarz-Singer D., Devall L.J., Klinkefus B.A., Weishaar R.E. Differential inhibition of human neutrophil functions Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase . Biochem Pharmacol. 40:1990;699-707.
26. Grady P.G., Thomas L.L. Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils. Biochim Biophys Acta. 885:1986;282-293.
27. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils Effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness . J Pharmacol Exp Ther. 253:1990;688-697.
28. ++ dependent protein kinase. Biochem Biophys Res Commun. 135:1986;397-402.
29. Seamon K.B., Daly J.W. Forskolin Its biological and chemical properties . Adv Cyclic Nucleotide Protein Phosphorylation Res. 20:1986;1-150.
30. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 11:1990;150-155.
31. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 142:1987;436-440.
32. Reeves M.L., Leigh B.K., England P.J. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle Implications for the mechanism of action of selective phosphodiesterase inhibitors . Biochem J. 241:1987;535-541.
33. 2+ influx following receptor activation. Trends Pharmacol Sci. 12:1991;289-292.
34. Teixeira M.M., Gristwood R.W., Cooper N., Hellewell P.G. Phosphodiesterase (PDE)4 inhibitors Anti-inflammatory drugs of the future? Trends Pharmacol Sci. 18:1997;164-170.
35. Barsony J., Marx S.J. Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. Proc Natl Acad Sci USA. 87:1990;1188-1192.
36. Mueller H., Montoya B., Sklar L.A. Reversal of inhibitory pathways in neutrophils by protein kinase antagonists A rational approach to the restoration of depressed cell function? J Leukoc Biol. 52:1992;400-406.
37. Krause K.H., Lew D.P. Bacterial toxins and neutrophil activation. Semin Hematol. 25:1988;112-122.
38. i. Naunyn Schmiedebergs Arch Pharmacol. 344:1991;682-690.
39. Elferink J.G.R., De Koster B.M. The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. Eur J Pharmacol. 246:1993;157-161.
40. Quinn M.T., Parkos C.A., Walker L., Orkin S.H., Dinauer M.C., Jesaitis A.J. Association of Ras-related protein with cytochrome b of human neutrophils. Nature. 342:1989;198-200.
41. 558 of NADPH oxidase by phosphorylation of Rap1A. Science. 254:1991;1794-1796.
42. Tyagi S.R., Olson S.C., Burnham D.N., Lambeth J.D. Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J Biol Chem. 266:1991;3498-3504.
43. Nielson C.P., Bayer C., Hodson S., Hadjokas N. Regulation of the respiratory burst by cyclic 3′,5′-AMP, an association with inhibition of arachidonic acid release. J Immunol. 149:1992;4036-4040.
44. 2+ ionophore through calmodulin-dependent processes. J Immunol. 138:1987;1201-1207.
45. Mitsuyama T., Takeshige K., Furuno T., Tanaka T., Hidaka K., Abe M., Hara N. An inhibitor of cyclic AMP-dependent protein kinase enhances the superoxide production of human neutrophils stimulated by N-formyl-methionyl-leucyl-phenylalanine. Mol Cell Biochem. 145:1995;19-24.
46. Beavo J.A., Conti M., Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 46:1994;399-405.
47. Nielson C.P., Vestal R.E., Sturm R.J., Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol. 86:1990;801-808.
48. Iannone M.A., Wolberg G., Zimmerman T.P. Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of adenylate cyclase response to endogenously produced adenosine. J Biol Chem. 264:1989;20177-20180.
49. Cronstein B.N., Rosenstein E.D., Kramer S.B., Weissmann G., Hirschhorn R. Adenosine, a physiological modulator of superoxide anion generation by human neutrophils. J Immunol. 135:1985;1366-1371.
50. Rosengren S., Bong G.W., Firestein G.S. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol. 154:1995;5444-5451.
51. Müller T., Engels P., Fozard J.R. Subtypes of the type 4 cAMP phosphodiesterases Structure, regulation and selective inhibition . Trends Pharmacol Sci. 17:1996;294-298.
52. Suttorp N., Weber U., Welsch T., Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 91:1993;1421-1428.